We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 7,236

Indefiniteness Again Leads To Unsuccessful IPR Challenge
  • Jones Day
  • USA
  • October 18 2018

The PTAB may institute IPR proceedings only on the basis of certain prior art that is potentially invalidating under 102 (novelty) or 103


Is Your Insurance Program Ready for California's New Data Privacy Law?
  • Jones Day
  • USA
  • October 18 2018

In June 2018, California enacted the toughest data privacy law in the United States. Companies doing business in California may have to make


Department of Labor Extends PAID Program for Resolving Employer FLSA Violations
  • Jones Day
  • USA
  • October 18 2018

The DOL confirmed that after an initial six-month pilot, the Payroll Audit Independent Determination program, known as the PAID program, will continue


Pennsylvania's Commission Continues to Probe the Value of Active Management
  • Jones Day
  • USA
  • October 18 2018

The Commission in Pennsylvania that has been focusing on the management fees being paid by Pennsylvania's two largest public pension plans held the


Pennsylvania’s Commission Continues to Probe the Value of Active Management
  • Jones Day
  • USA
  • October 17 2018

Pennsylvania's Commission was told at the September hearing regarding the PSERS and SERS probe that $3.8 billion in investment fees have gone


New Law Requires Disclosure of Biologic Patent Settlement Agreements to Antitrust Authorities
  • Jones Day
  • USA
  • October 17 2018

Last week, the Patient Right to Know Drug Prices Act ("Act") became law. The Act requires pharmaceutical companies to disclose to antitrust agencies


Texas Supreme Court to Further Examine Disclaimer of Reliance Clauses
  • Jones Day
  • USA
  • October 17 2018

The Texas Supreme Court is scheduled to review reliance disclaimer clauses and their enforceability in December 2018 and may provide further guidance


Pharmaceutical Company Agrees to $625 Million False Claims Act Settlement
  • Jones Day
  • USA
  • October 17 2018

The civil settlement is one the largest FCA settlements in recent years. The Department of Justice ("DOJ") recently announced that it agreed with


Antitrust Alert: First Successful Private Antitrust Merger Challenge Leads to Divestiture Order
  • Jones Day
  • USA
  • October 17 2018

A federal district court has ordered a defendant in private antitrust litigation to divest a manufacturing plant following a competitor's merger


Dawn Raid DerailmentA Cautionary Tale
  • Jones Day
  • European Union
  • October 17 2018

To enforce EU competition rules, the Commission has the authority to conduct unannounced inspections...